| Product Code: ETC13331704 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa Oncology Anti-Cancer Drugs Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa Oncology Anti-Cancer Drugs Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa Oncology Anti-Cancer Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Africa Oncology Anti-Cancer Drugs Market - Industry Life Cycle |
3.4 Africa Oncology Anti-Cancer Drugs Market - Porter's Five Forces |
3.5 Africa Oncology Anti-Cancer Drugs Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa Oncology Anti-Cancer Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Africa Oncology Anti-Cancer Drugs Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.8 Africa Oncology Anti-Cancer Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Africa Oncology Anti-Cancer Drugs Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.10 Africa Oncology Anti-Cancer Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Africa Oncology Anti-Cancer Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa Oncology Anti-Cancer Drugs Market Trends |
6 Africa Oncology Anti-Cancer Drugs Market, 2021 - 2031 |
6.1 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Chemotherapy, 2021 - 2031 |
6.1.3 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Immunotherapy, 2021 - 2031 |
6.1.4 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Hormone Therapy, 2021 - 2031 |
6.1.5 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Targeted Therapy, 2020 - 2028 |
6.1.6 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Precision Medicine, 2020 - 2028 |
6.2 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Lung Cancer, 2021 - 2031 |
6.2.3 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Breast Cancer, 2021 - 2031 |
6.2.4 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Prostate Cancer, 2021 - 2031 |
6.2.5 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Colorectal Cancer, 2021 - 2031 |
6.2.6 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Leukemia, 2020 - 2028 |
6.3 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.3.3 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Intravenous, 2021 - 2031 |
6.3.4 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Subcutaneous, 2021 - 2031 |
6.3.5 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Topical, 2021 - 2031 |
6.3.6 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Intramuscular, 2021 - 2031 |
6.4 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Targeted Therapy, 2021 - 2031 |
6.4.3 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Immunotherapy, 2021 - 2031 |
6.4.4 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Hormone Therapy, 2020 - 2028 |
6.4.5 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Chemotherapy, 2020 - 2028 |
6.4.6 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Combination Therapy, 2020 - 2028 |
6.5 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Distribution Channel, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Hospital Pharmacies, 2020 - 2028 |
6.5.3 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Retail Pharmacies, 2020 - 2028 |
6.5.4 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Online Pharmacies, 2020 - 2028 |
6.5.5 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Specialty Pharmacies, 2020 - 2028 |
6.5.6 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Mail Order Pharmacies, 2020 - 2028 |
7 Africa Oncology Anti-Cancer Drugs Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.2.1 South Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.2.2 Egypt Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.2.3 Nigeria Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.2.4 Rest of Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.3 Africa Oncology Anti-Cancer Drugs Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
7.3.1 South Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.3.2 Egypt Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.3.3 Nigeria Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.3.4 Rest of Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.4 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.4.1 South Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.4.2 Egypt Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.4.3 Nigeria Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.4.4 Rest of Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
7.5.1 South Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
7.5.2 Egypt Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
7.5.3 Nigeria Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
7.5.4 Rest of Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
7.6 Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6.1 South Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6.2 Egypt Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6.3 Nigeria Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6.4 Rest of Africa Oncology Anti-Cancer Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Africa Oncology Anti-Cancer Drugs Market Key Performance Indicators |
9 Africa Oncology Anti-Cancer Drugs Market - Export/Import By Countries Assessment |
10 Africa Oncology Anti-Cancer Drugs Market - Opportunity Assessment |
10.1 Africa Oncology Anti-Cancer Drugs Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa Oncology Anti-Cancer Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
10.3 Africa Oncology Anti-Cancer Drugs Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
10.4 Africa Oncology Anti-Cancer Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10.5 Africa Oncology Anti-Cancer Drugs Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
10.6 Africa Oncology Anti-Cancer Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
11 Africa Oncology Anti-Cancer Drugs Market - Competitive Landscape |
11.1 Africa Oncology Anti-Cancer Drugs Market Revenue Share, By Companies, 2022 |
11.2 Africa Oncology Anti-Cancer Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here